Search
Filter Results
Displaying 761–770 of 865 results for “vision connection”
-
Feb 21, 2023
Foundation Fighting Blindness to Host their Spring VisionWalks
Foundation NewsThese VisionWalk events taking place this spring will raise awareness and fund research finding treatments and cures for blinding retinal diseases.
-
Jan 9, 2023
Fearless Sister Duo Finding Hope
Beacon StoriesApril LuFriu and Melissa Escobio are sisters and best friends who do just about everything together, including having retinitis pigmentosa (RP).
-
Jan 6, 2023
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
In the PressThe investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
-
Jan 3, 2023
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
Research NewsThe company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
Dec 2, 2022
Your Dollar Makes a Difference
Foundation NewsAt the Foundation Fighting Blindness, a dollar is more than just a dollar – it’s a path to transforming lives. But just where does your donation go?
-
Dec 2, 2022
Eye on the Cure Podcast | Episode 36: Sue Bramhall
Eye on the CureDecember 2, 2022. Host Ben Shaberman interviews Sue Bramhall.
-
Nov 10, 2022
Foundation NewsUni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
-
Nov 4, 2022
Eye on the Cure Podcast | Episode 34: LambdaVision
Eye on the CureNovember 4, 2022. Ben Shaberman talks with LambdaVision’s Nicole Wagner, PhD, and Jordan Greco, PhD.
-
My name is Terry Super. As a Professional Engineer, my career was defined by technical and left-brained stuff. Today, I’m semi-retired and have been relaxing by doing some creative and right-brained stuff - oil painting.
-
May 12, 2022
Opus Genetics Appoints Jennifer Hunt Chief Development Officer
In the PressBiopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients.